| Accession Number | 0000874015-26-000239 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 9, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Officer | Common Stock | โ | Jul 7, 2026 | Sale | 5,536 | $83.58 | $462,693.34 | 75,018 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Common Stock | โ | Jul 7, 2026 | Other Acquisition or Disposition | 15,000 | $0.00 | $0.00 | 15,000 | Indirect | by Trust | View Details | |
EVP, Chief Scientific Officer | Common Stock | โ | Jul 7, 2026 | Sale | 15,000 | $85.46 | $1,281,930.00 | 0 | Indirect | by Trust | View Details | |
EVP, Chief Scientific Officer | Restricted Stock Unit | Derivative | Jul 7, 2026 | Other Acquisition or Disposition | 15,000 | $0.00 | $0.00 | 12,109 | Direct | โ | View Details |